CLCR Call: October 19, 2020

For Public Health

At a glance

The October 19, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on COVID-19 test reporting tool, effects of increased SARS-CoV-2 testing, CDC's use of COVID-19 testing data, and an FDA update.

Format: MP3
Language: English (US)
Size: 29 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

National Healthcare Safety Network (NHSN) Point-of-Care Test Reporting Tool for COVID-19 in Long-Term Care Facilities: Kathy Bridson, CDC Division of Healthcare Quality Promotion (DHQP)

2020-2021 Influenza Testing Issues: Tim Uyeki, CDC Influenza Division (ID)

Effects of Increased SARS-CoV-2 Testing on Laboratory Services: An Emerging Infections Network (EIN) Survey: Dan Diekema, University of Iowa

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

How Does CDC Use COVID-19 Laboratory Testing Data?: Jason Hall, CDC Division of Preparedness and Emerging Infections (DPEI) and Ed Lockhart, CDC Division of Laboratory Systems (DLS)

Meeting Materials

Content Source
About this page
Published: November 20, 2024
Updated: October 19, 2020

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: October 19, 2020

The information on this page was last reviewed by subject matter experts to ensure accuracy.